Strides Pharma Science Revenue

In the fiscal year ending March 31, 2025, Strides Pharma Science had annual revenue of 45.65B INR with 12.69% growth. Strides Pharma Science had revenue of 11.90B in the quarter ending March 31, 2025, with 9.81% growth.

Revenue

45.65B

Revenue Growth

+12.69%

P/S Ratio

1.71

Revenue / Employee

14.90M

Employees

3,065

Market Cap

77.90B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	45.65B	5.14B	12.69%
Mar 31, 2024	40.51B	3.63B	9.83%
Mar 31, 2023	36.88B	6.18B	20.13%
Mar 31, 2022	30.70B	-2.46B	-7.41%
Mar 31, 2021	33.16B	5.64B	20.49%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Reliance Industries	9,646.93B
HDFC Bank	2,728.47B
Tata Consultancy Services	2,553.24B
Bharti Airtel	1,729.85B
ICICI Bank	2,006.54B
State Bank of India	3,429.39B
Infosys	1,647.16B
Life Insurance Corporation of India	8,901.58B

Revenue Rankings

Strides Pharma Science News

7 weeks ago - Strides Pharma receives USFDA approval for Celecoxib Capsules - Business Upturn
2 months ago - Strides Pharma incorporates new subsidiary ‘Pivot Path’ to boost life sciences and digital innovation - Business Upturn
5 months ago - Strides Pharma shares surge 5% as revenue jumps 15% YoY in Q3 FY25 - Business Upturn
5 months ago - Strides Pharma Q3 FY25 Results: Revenue up 15% YoY to Rs 1,154 crore, Net Profit up 60% YoY - Business Upturn
5 months ago - Strides Pharma receives USFDA approval for acetaminophen and ibuprofen tablets, expanding OTC portfolio - Business Upturn

More News